ANDE Stock

Rapid DNA Analysis Solutions

Sign up today and learn more about ANDE Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About ANDE Stock

ANDE is dedicated to the development and commercialization of Rapid DNA products for human forensic identification, biothreat detection, and clinical diagnostics. The company believes that moving DNA analysis from the laboratory to the field will dramatically improve societal safety and health. By reducing crime, exonerating the innocent, monitoring borders, and reuniting families, Rapid DNA represents a fundamental opportunity for the public and private sectors to protect the innocent.

Funding History

November 2016$16.9M
June 2018$25.5M


Founder & Chairman, Board of Directors

Dr. Richard Selden

Chief Scientific Officer

Dr. Richard Selden


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: